Related Experiment Video
Updated: Feb 24, 2026

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
Published on: April 21, 2019
Serum Diamine Oxidase in Pseudoallergy in the Pediatric Population
Joanna Kacik1, Barbara Wróblewska2, Sławomir Lewicki3
1Department of Pediatrics, Pediatric Nephrology and Allergology, Military Institute of Medicine, 128 Szaserów, 04-141, Warsaw, Poland. jkacik@wim.mil.pl.
Abstract:
Histamine intolerance (pseudoallergy) is a poorly investigated type of food hypersensitivity. The main enzyme responsible for histamine degradation in the extracellular matrix is diamine oxidase (DAO). Disturbances in the concentration or activity of DAO may lead to the development of clinical signs of allergy. The aim of the present work was to assess the DAO concentration, peripheral blood morphology, lymphocytes phenotyping (CD3+, CD4+, CD8+, CD19+, NK cells, NKT cells, and activated T-cells), and natural regulatory Treg (nTregs) cell population (CD4+, CD25+, CD127low, and FoxP3) in 34 pediatric patients with histamine-dependent syndromes. Patients were divided into two groups: classical allergy and pseudoallergy on the basis of IgE concentration. The investigation was based on the analysis of peripheral blood samples. A significantly lower serum DAO, both total and specific IgE, concentration was found in the pseudoallergy group compared with the allergy group. There were no significant differences in blood morphology or lymphocyte populations. A similar level of nTreg lymphocytes was also found in both groups, although it was lower than that present in healthy individuals. The findings suggest that the serum DAO is responsible for the symptoms of histamine intolerance. Moreover, a general decrease in nTreg cells in comparison with healthy individuals may lead to symptom aggravation.
Related Concept Videos
Allergic Reactions: Anaphylaxis
Allergic Reactions
Drug Toxicity: Allergic Reactions
Allergic Drug Reactions
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Drug Dosing: Infants and Children

